Key Takeaways Following MAJIC-PV

Opinion
Video

Gabriela Hobbs, MD, and Timothy Mok, PharmD, BCPS, BCOP, close the discussion with key takeaways for payers to consider related to ruxolitinib and insights on future research.

Recent Videos
2 experts in this video
2 experts in this video
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, an expert on myelofibrosis
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, an expert on myelofibrosis
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, an expert on myelofibrosis
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, an expert on myelofibrosis
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, an expert on myelofibrosis
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, an expert on myelofibrosis
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, an expert on myelofibrosis
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, an expert on myelofibrosis
Related Content
© 2025 MJH Life Sciences

All rights reserved.